These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1793022)

  • 1. 15-Deoxyspergualin (15-DOS) for therapy in an animal model of multiple sclerosis (MS): disease modifying activity on acute and chronic relapsing experimental allergic encephalomyelitis (EAE).
    Schorlemmer HU; Seiler FR
    Agents Actions; 1991 Sep; 34(1-2):156-60. PubMed ID: 1793022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects of 15-deoxyspergualin in acute and chronic relapsing experimental allergic encephalomyelitis (EAE) as models for multiple sclerosis (MS).
    Schorlemmer HU; Seiler FR
    Drugs Exp Clin Res; 1991; 17(10-11):461-9. PubMed ID: 1841035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic activity of malononitrilamides (MNA 279 and MNA 715) on acute and chronic, relapsing, experimental, allergic encephalomyelitis (EAE).
    Schorlemmer HU; Bartlett RR
    Drugs Exp Clin Res; 1997; 23(5-6):175-81. PubMed ID: 9515227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic relapsing experimental allergic encephalomyelitis in Lewis rats as a model of multiple sclerosis].
    Zaprianova E; Deleva D; Bakalska M; Filchev N
    Morfologiia; 1997; 112(6):25-8. PubMed ID: 9606089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SRI 62-834, a cyclic ether analogue of the phospholipid ET-18-OCH3, displays long-lasting beneficial effect in chronic relapsing experimental allergic encephalomyelitis in the Lewis rat. Comparison with cyclosporin and (Val2)-dihydrocyclosporin effects in clinical, functional and histological studies.
    Chabannes D; Ryffel B; Borel JF
    J Autoimmun; 1992 Apr; 5(2):199-211. PubMed ID: 1627233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amelioration of acute and relapsing stages of the experimental allergic encephalomyelitis by cobra toxins.
    Mohamed A; Reid PF; Raymond L; Dufan T
    Biomed Sci Instrum; 2006; 42():399-404. PubMed ID: 16817641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with rapamycin ameliorates clinical and histological signs of protracted relapsing experimental allergic encephalomyelitis in Dark Agouti rats and induces expansion of peripheral CD4+CD25+Foxp3+ regulatory T cells.
    Donia M; Mangano K; Amoroso A; Mazzarino MC; Imbesi R; Castrogiovanni P; Coco M; Meroni P; Nicoletti F
    J Autoimmun; 2009 Sep; 33(2):135-40. PubMed ID: 19625166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of experimental allergic encephalomyelitis by 15-deoxyspergualin.
    Yamamura T; Da-Lin Y; Satoh J; Tabira T
    J Neurol Sci; 1987 Dec; 82(1-3):101-10. PubMed ID: 3502003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the pharmacological control of experimental allergic encephalomyelitis (EAE) and the implications for multiple sclerosis treatment.
    Bolton C
    Mult Scler; 1995 Nov; 1(3):143-9. PubMed ID: 9345444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic treatment against GM-CSF, but not IL-17, abolishes relapses in a chronic murine model of multiple sclerosis.
    Uyttenhove C; Gaignage M; Donckers D; Nasr Z; Cheou P; van Snick J; D'Auria L; van Pesch V
    Eur J Immunol; 2018 Nov; 48(11):1883-1891. PubMed ID: 30216414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malononitrilamides (MNA 279 and MNA 715) have therapeutic activity in acute and chronic relapsing experimental allergic encephalomyelitis (EAE).
    Schorlemmer HU; Bartlett RR
    Inflamm Res; 1997 Aug; 46 Suppl 2():S163-4. PubMed ID: 9297562
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of gonadectomy on the clinical course of chronic experimental allergic encephalomyelitis.
    Trooster WJ; Teelken AW; Gerrits PO; Lijnema TH; Loof JG; Minderhoud JM; Nieuwenhuis P
    Clin Neurol Neurosurg; 1996 Aug; 98(3):222-6. PubMed ID: 8884093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological follow-up of acute and chronic experimental allergic encephalomyelitis in the Lewis rat.
    Deguchi K; Takeuchi H; Miki H; Yamada A; Touge T; Terada S; Nishioka M
    Eur Arch Psychiatry Clin Neurosci; 1992; 242(1):1-5. PubMed ID: 1390949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Treatment with Zinc Aspartate and Intravenous Immunoglobulins (IVIGs) Ameliorates Experimental Autoimmune Encephalomyelitis (EAE).
    Straubel D; Thielitz A; Reinhold A; Grüngreiff K; Reinhold D
    J Immunol Res; 2018; 2018():5982169. PubMed ID: 30356433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early pregnancy factor suppresses experimental autoimmune encephalomyelitis induced in Lewis rats with myelin basic protein and in SJL/J mice with myelin proteolipid protein peptide 139-151.
    Zhang B; Harness J; Somodevilla-Torres MJ; Hillyard NC; Mould AW; Alewood D; Love SG; Alewood PF; Greer JM; Cavanagh AC; McCombe PA; Morton H
    J Neurol Sci; 2000 Dec; 182(1):5-15. PubMed ID: 11102634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are current disease-modifying therapeutics in multiple sclerosis justified on the basis of studies in experimental autoimmune encephalomyelitis?
    Farooqi N; Gran B; Constantinescu CS
    J Neurochem; 2010 Nov; 115(4):829-44. PubMed ID: 20807309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive activity of 15-deoxyspergualin (15-DOS) on various models of rheumatoid arthritis.
    Schorlemmer HU; Bartlett RR; Schleyerbach R; Seiler FR
    Drugs Exp Clin Res; 1991; 17(10-11):471-84. PubMed ID: 1841036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cop 1 as a candidate drug for multiple sclerosis.
    Teitelbaum D; Arnon R; Sela M
    J Neural Transm Suppl; 1997; 49():85-91. PubMed ID: 9266417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral glatiramer acetate in experimental autoimmune encephalomyelitis: clinical and immunological studies.
    Teitelbaum D; Aharoni R; Klinger E; Kreitman R; Raymond E; Malley A; Shofti R; Sela M; Arnon R
    Ann N Y Acad Sci; 2004 Dec; 1029():239-49. PubMed ID: 15681762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic relapsing experimental allergic encephalomyelitis in the Lewis rat.
    Feurer C; Prentice DE; Cammisuli S
    J Neuroimmunol; 1985 Dec; 10(2):159-66. PubMed ID: 3877741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.